Impax Asset Management Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
VCM
VPM
WA
CAM
CCA
Impax Asset Management Group's RGEN Position: Q2 2026 in Review
Impax Asset Management Group reduced its Repligen (RGEN) stake by 9.6% in Q2 2026, selling an estimated $5.15M and leaving 396,513 shares worth $54.1M. The position accounts for 0.35% of the portfolio, ranked #63.
Impax Asset Management Group first reported a position in RGEN in Q1 2020 and has held it in 26 quarters since. The position peaked at $214M in Q4 2021. 343 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Impax Asset Management Group held 396,513 shares of Repligen worth $54.1M as of Q2 2026.
- Impax Asset Management Group sold 41,955 Repligen shares in Q2 2026, an estimated $5.15M.
- Repligen made up 0.35% of Impax Asset Management Group's portfolio in Q2 2026, its #63 holding.
- Impax Asset Management Group first reported a position in Repligen in Q1 2020 and has held it in 26 quarters since.
- Impax Asset Management Group's Repligen position peaked at $214M in Q4 2021.
- 343 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.